These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 9339270)

  • 1. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.
    Nasri A; Sghaier I; Neji A; Gharbi A; Abida Y; Mrabet S; Gargouri A; Djebara MB; Kacem I; Gouider R
    J Mov Disord; 2024 Apr; 17(2):158-170. PubMed ID: 38290492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and Characterization of a Human-Derived and Induced Pluripotent Stem Cell (iPSC) Line from an Alzheimer's Disease Patient with Neuropsychiatric Symptoms.
    Sagar R; Zivko C; Xydia A; Weisman DC; Lyketsos CG; Mahairaki V
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.
    Cacabelos R
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
    Qian W; Fischer CE; Schweizer TA; Munoz DG
    Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural genetics of Alzheimer's disease: a comprehensive review.
    Flirski M; Sobow T; Kloszewska I
    Arch Med Sci; 2011 Apr; 7(2):195-210. PubMed ID: 22291757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.
    Panza F; Seripa D; D'Onofrio G; Frisardi V; Solfrizzi V; Mecocci P; Pilotto A
    Int J Alzheimers Dis; 2011 Apr; 2011():721457. PubMed ID: 21559196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolving the relationship between ApolipoproteinE and depression.
    Slifer MA; Martin ER; Gilbert JR; Haines JL; Pericak-Vance MA
    Neurosci Lett; 2009 May; 455(2):116-9. PubMed ID: 19368858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics.
    Cacabelos R
    Neuropsychiatr Dis Treat; 2007 Jun; 3(3):303-33. PubMed ID: 19300564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics and therapeutic prospects in dementia.
    Cacabelos R
    Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():28-47. PubMed ID: 18344047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.
    Cacabelos R
    Mol Diagn Ther; 2007; 11(6):385-405. PubMed ID: 18078356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease.
    Pritchard AL; Harris J; Pritchard CW; Coates J; Haque S; Holder R; Bentham P; Lendon CL
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):123-6. PubMed ID: 16980336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.
    Scarmeas N; Brandt J; Albert M; Devanand DP; Marder K; Bell K; Ciappa A; Tycko B; Stern Y
    Neurology; 2002 Apr; 58(8):1182-8. PubMed ID: 11971084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE-related frequency of cognitive and noncognitive symptoms in dementia.
    Cacabelos R; Rodríguez B; Carrera C; Caamaño J; Beyer K; Lao JI; Sellers MA
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):693-706. PubMed ID: 9121226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
    Engelborghs S; Dermaut B; Mariën P; Symons A; Vloeberghs E; Maertens K; Somers N; Goeman J; Rademakers R; Van den Broeck M; Pickut B; Cruts M; Van Broeckhoven C; De Deyn PP
    Neurobiol Aging; 2006 Feb; 27(2):285-92. PubMed ID: 16399213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoprotein E and Alzheimer dementia. Personal results and brief literature review].
    Förstl H; Czech C; Sattel H; Geiger-Kabisch C; Besthorn C; Kreger S; Mönning U; Hartmann T; Masters C; Beyreuther K
    Nervenarzt; 1994 Nov; 65(11):780-6. PubMed ID: 7816155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism and behavioral and psychological symptoms of dementia in patients with Alzheimer disease.
    Chen CS; Ouyang P; Yeh YC; Lai CL; Liu CK; Yen CF; Ko CH; Yen JY; Liu GC; Juo SH
    Alzheimer Dis Assoc Disord; 2012; 26(2):135-9. PubMed ID: 21617520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues.
    Issa AM; Keyserlingk EW
    Can J Psychiatry; 2000 Dec; 45(10):917-22. PubMed ID: 11190361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral changes associated with different apolipoprotein E genotypes in dementia.
    Cacabelos R; Rodríguez B; Carrera C; Beyer K; Lao JI; Sellers MA
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S27-34. PubMed ID: 9339270
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.